143 related articles for article (PubMed ID: 37751517)
1. Does Media Choice Matter When Evaluating the Performance of Hydroxypropyl Methylcellulose Acetate Succinate-Based Amorphous Solid Dispersions?
Bapat P; Paul S; Thakral NK; Tseng YC; Taylor LS
Mol Pharm; 2023 Nov; 20(11):5714-5727. PubMed ID: 37751517
[TBL] [Abstract][Full Text] [Related]
2. Interplay of Drug-Polymer Interactions and Release Performance for HPMCAS-Based Amorphous Solid Dispersions.
Bapat P; Paul S; Tseng YC; Taylor LS
Mol Pharm; 2024 Mar; 21(3):1466-1478. PubMed ID: 38346390
[TBL] [Abstract][Full Text] [Related]
3. Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: A review from bench to clinic.
Butreddy A
Eur J Pharm Biopharm; 2022 Aug; 177():289-307. PubMed ID: 35872180
[TBL] [Abstract][Full Text] [Related]
4. Dissolution Kinetics of Nifedipine-Ionizable Polymer Amorphous Solid Dispersion: Comparison Between Bicarbonate and Phosphate Buffers.
Sakamoto A; Sugano K
Pharm Res; 2021 Dec; 38(12):2119-2127. PubMed ID: 34931285
[TBL] [Abstract][Full Text] [Related]
5. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
Yang R; Mann AKP; Van Duong T; Ormes JD; Okoh GA; Hermans A; Taylor LS
Mol Pharm; 2021 May; 18(5):2066-2081. PubMed ID: 33784104
[TBL] [Abstract][Full Text] [Related]
6. Insights into the Release Mechanisms of ITZ:HPMCAS Amorphous Solid Dispersions: The Role of Drug-Rich Colloids.
Nunes PD; Pinto JF; Henriques J; Paiva AM
Mol Pharm; 2022 Jan; 19(1):51-66. PubMed ID: 34919407
[TBL] [Abstract][Full Text] [Related]
7. Fed- and Fasted-State Performance of Pretomanid Amorphous Solid Dispersions Formulated with an Enteric Polymer.
Nguyen HT; Van Duong T; Jaw-Tsai S; Bruning-Barry R; Pande P; Taneja R; Taylor LS
Mol Pharm; 2023 Jun; 20(6):3170-3186. PubMed ID: 37220082
[TBL] [Abstract][Full Text] [Related]
8. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
Sun DD; Ju TC; Lee PI
Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
[TBL] [Abstract][Full Text] [Related]
9. Effects of Surfactants on Itraconazole-HPMCAS Solid Dispersion Prepared by Hot-Melt Extrusion I: Miscibility and Drug Release.
Solanki NG; Lam K; Tahsin M; Gumaste SG; Shah AV; Serajuddin ATM
J Pharm Sci; 2019 Apr; 108(4):1453-1465. PubMed ID: 30395834
[TBL] [Abstract][Full Text] [Related]
10. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
Purohit HS; Taylor LS
Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
[TBL] [Abstract][Full Text] [Related]
11. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
Indulkar AS; Lou X; Zhang GGZ; Taylor LS
Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
[TBL] [Abstract][Full Text] [Related]
12. Generality of Enhancing the Dissolution Rates of Free Acid Amorphous Solid Dispersions by the Incorporation of Sodium Hydroxide.
Zhang HJ; Chiang CW; Maschmeyer-Tombs T; Conklin B; Napolitano JG; Lubach JW; Nagapudi K; Mao C; Chen Y
Mol Pharm; 2024 Jun; ():. PubMed ID: 38836777
[TBL] [Abstract][Full Text] [Related]
13. Effect of Buffer pH and Concentration on the Dissolution Rates of Sodium Indomethacin-Copovidone and Indomethacin-Copovidone Amorphous Solid Dispersions.
Chiang CW; Tang S; Mao C; Chen Y
Mol Pharm; 2023 Dec; 20(12):6451-6462. PubMed ID: 37917181
[TBL] [Abstract][Full Text] [Related]
14. Improved dissolution of an enteric polymer and its amorphous solid dispersions by polymer salt formation.
Qi Q; Taylor LS
Int J Pharm; 2022 Jun; 622():121886. PubMed ID: 35661745
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Phase Transformations for Amorphous Solid Dispersions of a Weakly Basic Drug upon Dissolution in Biorelevant Media.
Elkhabaz A; Sarkar S; Simpson GJ; Taylor LS
Pharm Res; 2019 Oct; 36(12):174. PubMed ID: 31667638
[TBL] [Abstract][Full Text] [Related]
16. Multiscale Computational Modeling of the Nanostructure of Solid Dispersions of Hydroxypropyl Methylcellulose Acetate Succinate (HPMCAS) and Phenytoin.
Huang W; Mandal T; Larson RG
Mol Pharm; 2017 Oct; 14(10):3422-3435. PubMed ID: 28829134
[TBL] [Abstract][Full Text] [Related]
17. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
Xie T; Taylor LS
Mol Pharm; 2016 Mar; 13(3):873-84. PubMed ID: 26791934
[TBL] [Abstract][Full Text] [Related]
18. Patterns of drug release as a function of drug loading from amorphous solid dispersions: A comparison of five different polymers.
Saboo S; Moseson DE; Kestur US; Taylor LS
Eur J Pharm Sci; 2020 Dec; 155():105514. PubMed ID: 32810579
[TBL] [Abstract][Full Text] [Related]
19. Hypromellose acetate succinate based amorphous solid dispersions via hot melt extrusion: Effect of drug physicochemical properties.
Sarabu S; Kallakunta VR; Bandari S; Batra A; Bi V; Durig T; Zhang F; Repka MA
Carbohydr Polym; 2020 Apr; 233():115828. PubMed ID: 32059882
[TBL] [Abstract][Full Text] [Related]
20. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
Sun DD; Lee PI
J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
